Emphasys On The Block After FDA Panel Rejection Of Pulmonary Valve

The end is near for Emphasys Medical. At the end of March, the company's ongoing business and assets will be put up for auction, serving as a disappointing end to the firm's nine-year effort to get its Zephyr Endobronchial Valve to market